https://hope.projects.umfiasi.ro/wp-content/uploads/2019/05/hope.jpg

The project

Context Programme: Erasmus+ Key Action: Cooperation for innovation and the exchange of good practices Action: Strategic Partnerships Field: Strategic Partnerships for […]

The activities

The project actions and results are the following: – Mapping research on situation/strategies/support institutions and specialists/best practices of the genetic consultancy/oncogenetics […]

1
Project Acronym

HOPE – How Oncogenetics Predicts & Educates

READ MORE
2
Project title

Promoters of advanced oncogenetics open online training and multimedia raise awareness on multidisciplinary assessment of patients and their families at risk […]

READ MORE
 
3
Ref. no.

2018-1-RO01-KA202-049189

READ MORE

Home

Every day, worldwide, millions of people fight a battle against cancer, undergoing devastating therapies that hugely impact on their Quality of Life. Over the next 2 decades, the number of new cases is expected to rise by about 70% (WHO, 2017). Oncogenetics can contribute to change this future scenario, addressing those people for which prevention is still possible and the disease’s onset avoidable.

This medical discipline, in progressive expansion, is focused on understanding and monitoring the genetic predispositions of persons at risk, because of mutations or family histories of cancer.

Through guided professional decisions, the implementation of evidence-based prevention strategies will lead to considerable improvements in clinical decisions and outcomes. In order to move towards this predictive system, it is essential to raise awareness of those vulnerable people and to empower them.

On this basis, it will be possible to facilitate an appropriate checking and an early detection of prodromes, as well as the modification of harmful habits and behaviours. The focus of the project is to raise awareness on the importance of the existence and expansion of oncogenetics, as a discipline depending on advances in understanding genes associated with inherited susceptibility to common adult malignancies.